Scholarly Index
Mariko Harada‐Shiba
Osaka University of Pharmaceutical Sciences; 10,370 total citations; 325 total publications; best world rank #61
Osaka University of Pharmaceutical Sciences
10,370Total citations
325Total publications
53H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lipoproteins and Cardiovascular Health | Lifetime | 498 | JP 15 | 97.96 |
| Cancer, Lipids, and Metabolism | Lifetime | 759 | JP 30 | 97.36 |
| Lipid metabolism and disorders | Lifetime | 488 | JP 26 | 95.08 |
| Cholesterol and Lipid Metabolism | Lifetime | 811 | JP 50 | 93.70 |
| Aortic Thrombus and Embolism | Lifetime | 399 | JP 66 | 77.51 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 100 | JP 1 | 97.52 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 294 | JP 16 | 92.37 |
| Lipid metabolism and disorders | 2021-2025 | 70 | JP 2 | 91.41 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 274 | JP 4 | 93.64 |
| Pharmaceutical Economics and Policy | 2021-2025 | 214 | JP 3 | 88.84 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 295 | JP 10 | 72.83 |
| Aortic Thrombus and Embolism | 2021-2025 | 61 | JP 22 | 67.59 |